Cryptosporidia / Microsporidia | Appendix B: Panel Roster and Financial Disclosures | Adult and Adolescent Opportunistic Infection | ClinicalInfo

Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.

Updated

Aug. 01, 2019

Reviewed

Aug. 01, 2019

Appendix B: Panel Roster and Financial Disclosures

Cryptosporidia/Microsporidia

Cryptosporidiosis and Microsporidiosis
Member		Financial Disclosure
Member		Company	Relationship
Desruisseaux, Mahalia	Albert Einstein College of Medicine	None	N/A
Didier, Elizabeth	University of California, Davis	None	N/A
Hlavsa, Michele	Centers for Disease Control and Prevention	None	N/A
Ward, Honorine	Tufts University School of Medicine	None	N/A
Weiss, Louis*	Albert Einstein College of Medicine	None	N/A
White, A. Clinton	University of Texas Medical Branch	None	N/A
Xiao, Lihua	Centers for Disease Control and Prevention	None	N/A
* Group lead Note: Members were asked to disclose all relationships from 12 months prior to the updated date. The period of reporting was from August 1, 2018, through August 1, 2019.

Download Guidelines

Section OnlyPDF (337.79 KB)
Full GuidelinePDF (3.78 MB)
Tables OnlyPDF (481.21 KB)